Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Cash Flows

v3.23.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 46,202 $ 66,837 $ 66,837
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, Amortization And Non-Cash Lease Expense 30,583   30,577
Accounts Receivable, Credit Loss Expense (Reversal) (90)   (3,377)
Gain (Loss) on Disposition of Assets (287)   (1,598)
Deferred income taxes (85)   2,746
Share-based Payment Arrangement, Noncash Expense 5,808   5,503
Changes in operating assets and liabilities:      
Increase (Decrease) in Accounts Receivable 82,927   81,220
Increase (Decrease) in Inventories 71,503   (71,108)
Increase (Decrease) in Prepaid Expense and Other Assets 23,101   (17,604)
Increase (Decrease) in Prepaid Expense and Other Assets (23,101)   17,604
Increase (Decrease) in Other Noncurrent Assets 837   1,443
Increase (Decrease) in Accounts Payable (95,423)   (20,823)
Increase (Decrease) in Accrued Liabilities (59,538)   (81,371)
Increase (Decrease) in Income Taxes Payable (10,941)   (11,004)
Increase (Decrease) in Other Operating Assets and Liabilities, Net 17,355   15,979
Increase (Decrease) in Other Noncurrent Liabilities 1,860   440
Net cash provided by operating activities 78,002   (33,788)
Cash flows from investing activities:      
Payments to Acquire Short-term Investments (98,203)   (44,877)
Proceeds from Sale, Maturity and Collection of Short-term Investments 570   984
Payments to Acquire Productive Assets 14,047   12,885
Net cash used in investing activities (111,680)   (56,778)
Cash flows from financing activities:      
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 2,678   2,512
Payment, Tax Withholding, Share-based Payment Arrangement (4,297)   (3,959)
Payments for Repurchase of Common Stock (15,293)   (217,317)
Payments of Dividends 18,649   19,151
Net cash used in financing activities (35,561)   (237,915)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 47   317
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (69,192)   (328,164)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance   435,240  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 361,049    
Supplemental disclosures of cash flow information:      
Income Taxes Paid 30,775   18,205
Supplemental disclosures of non-cash investing activities:      
Capital expenditures incurred but not yet paid 2,899   $ 6,702
Cash and Cash Equivalents, at Carrying Value $ 361,049 $ 435,240